Phenytoin overview - Metabolite interference in some immunoassays could be clinically important (multiple letters)

Archives of Pathology and Laboratory Medicine

Volumn 128, Issue 7, 2004, Pages 734-735

  Roberts, William L ^a   Rainey, Petrie M ^b   Soldin, Steven J ^c,d   Guo, Tiedong ^d   Wang, Edward ^e   Verjee, Zulfikarali ^f,g   Elin, Ronald J ^h  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^d GEORGETOWN UNIVERSITY   (United States)

^e Molecular Pathology Division   (United States)

^f UNIVERSITY OF TORONTO   (Canada)

^g HOSPITAL FOR SICK CHILDREN   (Canada)

^h University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 (3' HYDROXYPHENYL) 5 PHENYLHYDANTOIN; 5 (3',4' DIHYDROXYPHENYL) 5 PHENYLHYDANTOIN; 5 (4 HYDROXYPHENYL) 5 PHENYLHYDANTOIN; DRUG METABOLITE; GLUCURONIDE; PHENYTOIN; PHENYTOIN N GLUCURONIDE; UNCLASSIFIED DRUG;

CROSS REACTION; HEMODIALYSIS; IMMUNOASSAY; KIDNEY FAILURE; LETTER; PERITONEAL DIALYSIS;

CROSS REACTIONS; HUMANS; IMMUNOASSAY; KIDNEY FAILURE, CHRONIC; PHENYTOIN;

EID: 3042712423     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (0)